World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
101
Citations
33562
World Ranking
390
National Ranking
180

Medicine

D-Index
100
Citations
33829
World Ranking
8323
National Ranking
4303

Research.com Recognitions

  • 2005 - Fellow of American Physical Society (APS) Citation For insightful contributions to the theoretical description and the interpretation of experimental data of quantum fluid mixtures and mixture films

Overview

Michael D. Miller was affiliated with the United States Military Academy in the United States. Their research primarily focused on medicine, with extensive work in infectious diseases, epidemiology, virology, public health, environmental and occupational health, and general health professions.

Their academic output included significant contributions to HIV/AIDS research and interventions, HIV research and treatment, HIV and its intersection with drug use and sexual risk, HIV/AIDS drug development and treatment, opioid use disorder treatment, sex work and related issues, and substance abuse treatment and outcomes.

Among their recent publications were:

  • Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection, 2020, New England Journal of Medicine

Frequent coauthors collaborating with Michael D. Miller included:

  • Roman Shrestha
  • Colleen Mistler
  • Jeffrey A. Wickersham
  • Frederick L. Altice
  • John Gunstad

The venues where their work was often published included:

  • Drug and Alcohol Dependence
  • UNC Libraries
  • AIDS and Behavior
  • Journal of Community Health
  • The Lancet HIV

Their research had a focus on HIV/AIDS treatment and the impact of substance use on health outcomes. Their notable papers frequently addressed treatment-resistant HIV-1 infections and prevention strategies among vulnerable populations.

Michael D. Miller was recognized by the American Physical Society as a Fellow in 2005 for contributions related to quantum fluid mixtures and mixture films, reflecting a diverse academic background beyond the medical sciences.

Best Publications

  • Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.

    Joel E. Gallant;Schlomo Staszewski;Anton L. Pozniak;Edwin DeJesus

  • Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells

    Daria J. Hazuda;Peter Felock;Marc Witmer;Abigail Wolfe

  • Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines.

    Miller;Krangel

  • Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.

    Michael D. Miller;Chris M. Farnet;Frederic D. Bushman

  • Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

    Roy T. Steigbigel;David A. Cooper;Princy N. Kumar;Joseph E. Eron

  • Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

    Jeffrey L. Lennox;Edwin DeJesus;Adriano Lazzarin;Richard B. Pollard

  • Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

    David A. Cooper;Roy T. Steigbigel;Jose M. Gatell;Jurgen K. Rockstroh

  • Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

    Martin Markowitz;Bach-Yen Nguyen;Eduardo Gotuzzo;Fernando Mendo

  • Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

    Jonathan Z. Li;Roger Paredes;Heather J. Ribaudo;Evguenia S. Svarovskaia

  • A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.

    Daria J. Hazuda;Neville J. Anthony;Robert P. Gomez;Samson M. Jolly

  • Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

    Joseph J Eron;Benjamin Young;David A Cooper;Michael Youle

  • FLOG: A system to select ‘quasi-flexible’ ligands complementary to a receptor of known three-dimensional structure

    Michael D. Miller;Simon K. Kearsley;Dennis J. Underwood;Robert P. Sheridan

  • Traumatic Anterior Atlanto-occipital Dislocation

    Barry Powers;Michael D. Miller;Richard S. Kramer;Salutario Martinez

  • Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques

    Daria J. Hazuda;Steven D. Young;James P. Guare;Neville J. Anthony

  • Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study.

    Robert T Schooley;Peter Ruane;Robert A Myers;Gildon Beall

  • Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil

    Chris Westland;William Delaney;Huiling Yang;Shan-shan Chen

  • Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

    Christine Katlama;Steven G Deeks;Brigitte Autran;Javier Martinez-Picado

  • The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro

    William E. Delaney;Huiling Yang;Christopher E. Westland;Kalyan Das;Kalyan Das

  • In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA.

    Mark A Wainberg;Michael D Miller;Yudong Quan;Horacio Salomon

  • Efficacy of Tenofovir Disoproxil Fumarate in Antiretroviral Therapy-Naive and -Experienced Patients Coinfected with HIV-1 and Hepatitis B Virus

    Gregory J. Dore;David A. Cooper;Anton L. Pozniak;Edwin DeJesus

  • NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome

    Stefan Zeuzem;Masashi Mizokami;Stephen Pianko;Alessandra Mangia

Frequent Co-Authors

Hongmei Mo
Hongmei Mo Gilead Sciences (United States)
Daria J. Hazuda
Daria J. Hazuda MSD (United States)
Eric Lawitz
Eric Lawitz The University of Texas at Austin
Elisabetta Bianchi
Elisabetta Bianchi Institut Pasteur
Antonello Pessi
Antonello Pessi Schering-Plough
John G. McHutchison
John G. McHutchison Duke University
John W. Shiver
John W. Shiver United States Military Academy
Joseph P. Vacca
Joseph P. Vacca MSD (United States)
Robert P. Sheridan
Robert P. Sheridan MSD (United States)
Frederic D. Bushman
Frederic D. Bushman University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various interdisciplinary career pathways that go beyond traditional lab roles. For those interested in healthcare, becoming a functional medicine nurse practitioner salary specialist combines knowledge of biological sciences with patient-centered care, offering a rewarding, well-compensated career.

Alternatively, careers in healthcare administration and coding, such as a certified professional coder, are quickly growing fields that value scientific literacy and attention to detail, with flexible online programs available for certification.

For students or professionals facing unique challenges, such as having a criminal record, understanding the college degrees for felons can be crucial. Many online programs provide inclusive opportunities to pursue degrees in science and healthcare, helping individuals rebuild their careers.

Lastly, roles such as a child life specialist salary highlight career options that blend psychology, education, and biology, supporting children through medical experiences. These diverse pathways show how microbiology can be a foundation for meaningful careers in multiple sectors.

Best Scientists Citing Michael D. Miller

Recently Published Articles